Track topics on Twitter Track topics that are important to you
Democrats on the House Committee on Oversight and Government Reform said on Thursday they are launching an investigation into why prices for Multiple Sclerosis treatments have nearly quadrupled since 2004, and they sent letters requesting information from seven drugmakers. U.S. Representatives Elijah Cummings and Peter Welch sent the letters to Bayer AG, Biogen Inc, EMD Serono, Novartis AG, Roche Holding AG, Sanofi SA, and Teva Pharmaceutical Industries Inc. The lawmakers said in the letters that they were looking to determine whether drug companies are raising prices for MS drugs in lockstep with their competitors.
Original Article: House Democrats launch probe into MS drug pricingNEXT ARTICLE